TITLE:
A Study of the Safety and Efficacy Interferon-Gamma 1b in Patients With Idiopathic Pulmonary Fibrosis (IPF)

CONDITION:
Idiopathic Pulmonary Fibrosis

INTERVENTION:
Interferon-gamma 1b

SUMMARY:

      Study GIPF-001 is phase 3 study designed to determine the safety and efficacy of IFN-g 1b
      administered by subcutaneous injection; compared to placebo in patients with IPF who are
      unresponsive to steroids. 330 patients have been enrolled and were assigned to either a
      IFN-g 1b group or a placebo group.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 20 Years to 79 Years
Criteria:

        Male or Female, 20-79 years old
      
